[HTML][HTML] The regulation of exosome generation and function in physiological and pathological processes

Y Wang, T ** of exosomes in autoimmune diseases: a bibliometric analysis (2002–2021)
F Wu, J Gao, J Kang, X Wang, Q Niu, J Liu… - Frontiers in …, 2022 - frontiersin.org
Background Autoimmune diseases (AIDs) are a class of chronic disabling diseases
characterized by inflammation and damage to muscles, joints, bones, and internal organs …

The develo** landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian …

L Zhu, J Liu, J Chen, Q Zhou - Journal of hematology & oncology, 2021 - Springer
The use of immune checkpoint blockade (ICB) using antibodies against programmed death
receptor (PD)-1, PD ligand (PD-L)-1, and cytotoxic T-lymphocyte antigen 4 (CTLA-4) has …

Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis

M Azimi, M Ghabaee, AN Moghadasi… - Immunologic …, 2018 - Springer
Multiple sclerosis (MS) is an autoimmune disease which is characterized by neuroaxonal
degeneration in the central nervous system. Impaired function of regulatory T cells (Tregs) is …

Advances on CD8+ Treg cells and their potential in transplantation

S Bézie, I Anegon, C Guillonneau - Transplantation, 2018 - journals.lww.com
Although cluster of differentiation (CD) 8+ regulatory T (Treg) cells have been in the last 20
years more studied since evidences of their role in tolerance as been demonstrated in …

The therapeutic potential of exosomes in lung cancer

H Liang, L Zhang, X Zhao, J Rong - Cellular Oncology, 2023 - Springer
Background Lung cancer (LC) is one of the most common malignancies globally. Besides
early detection and surgical resection, there is currently no effective curative treatment for …

Pro-inflammatory responses after peptide-based cancer immunotherapy

H Mahaki, H Ravari, G Kazemzadeh, E Lotfian… - Heliyon, 2024 - cell.com
Therapeutic vaccinations are designed to prevent cancer by inducing immune responses
against tumor antigens. in cancer cells, tumor-associated antigens (TAA) or tumor-specific …

Immunocyte derived exosomes: insight into the potential chemo-immunotherapeutic nanocarrier targeting the tumor microenvironment

M Basak, DK Chaudhary, R Takahashi… - ACS Biomaterials …, 2022 - ACS Publications
“Cancer” is a dreadful immune-pathological condition that is characterized by anti-
inflammatory and tumorigenic responses, elicited by the infiltrating immune cells in the …

[HTML][HTML] Orally administered exosomes suppress mouse delayed-type hypersensitivity by delivering miRNA-150 to antigen-primed macrophage APC targeted by …

K Nazimek, K Bryniarski, W Ptak… - International Journal of …, 2020 - mdpi.com
We previously discovered suppressor T cell-derived, antigen (Ag)-specific exosomes
inhibiting mouse hapten-induced contact sensitivity effector T cells by targeting antigen …